Clinical Trial Update: Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating Sym004 in combination with FOLFIRI for metastatic colorectal cancer was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Sym004

Snippet

Sponsor: Symphogen A/S | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-01-09